QR code

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE

Abstract Introduction Atogepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for migraine prevention; however, real-world data from the Middle East and North Africa (MENA) region remain limited. This study evaluated the efficacy and safety of atogepant in patients w...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Taoufik Alsaadi, Reem Suliman, Ahsan H. Khandoker, Mariam Nasser Aljaafari, Ghaith Alsabbagh, Mohammad Saidam, Khaled Hamoulila
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Adis, Springer Healthcare 2026-05-01
Reeks:Neurology and Therapy
Onderwerpen:
Atogepant
Safety
Efficacy
CGRP
Gepant
Migraine
Online toegang:https://doi.org/10.1007/s40120-026-00961-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items